This clinical trial studies how well the Decision Counseling Program works in increasing patient-physician shared decision making and participation in clinical trials for lung cancer patients. Decision aids help provide patients with information that may help them select a course of action related to their cancer care when more than one alternative is available. It also encourages shared decision making allowing patients and their providers to make health decisions together. Determining how patients make decisions about participating in a clinical trial may help doctors facilitate patient decision making and improve participation in lung cancer clinical trials.

PRIMARY OBJECTIVES:

I. Facilitate patient deliberation about participation in a lung cancer clinical trial using the Decision Counseling Program (DCP).

SECONDARY OBJECTIVES:

I. Document the extent to which patient values and preferences are incorporated into physician-patient shared decision making (SDM) about cancer clinical trials.

II. Assess changes in patient knowledge, anxiety, and decisional conflict related to clinical trial participation.

III. Characterize patient and physician experience with intervention exposure.

Inclusion Criteria:

• Patients diagnosed with lung cancer (Stages 0, 1, 2, 3, 4)
• Lung cancer patients for which there is an available interventional clinical trial open at Jefferson Kimmel Cancer Center
• Patients being treated by a lung medical oncologist on the Center City Campus of Thomas Jefferson University
• Able to provide informed consent
• English-speaking

Exclusion Criteria:

• Inability to communicate in English
• Unable to provide informed consent
• Not eligible for an open, actively accruing interventional trial at Jefferson